Genetic suppression features ABHD18 as a Barth syndrome therapeutic target
Genetic suppression features ABHD18 as a Barth syndrome therapeutic target Summary This Nature study used genome-wide genetic suppression screens in TAFAZZIN (TAZ)‑deficient human cells to identify modifiers of Barth syndrome…
